Advertisement

Topics

Inhibitex Company Profile

08:57 EST 13th December 2018 | BioPortfolio

We are a biopharmaceutical company focused on the discovery, development and commercialization of novel antibody-based products for the prevention and treatment of serious bacterial and fungal infections in the hospital setting. We currently have two product candidates in clinical development and four product candidates in preclinical development. Our product candidates have been developed based upon our expertise in MSCRAMM® proteins, for which we own or have licensed numerous patents and patent applications. MSCRAMM® proteins are located on the surface of pathogenic organisms, such as bacteria and fungi, and play a prominent role in the process of infection. These proteins enable organisms to initiate and maintain an infection by adhering to specific sites on human tissue or implanted medical devices. Our antibody-based product candidates are designed to bind to specific MSCRAMM® proteins, thereby reducing the incidence and severity of infections.
Our lead product candidate, Veronate®, is being developed for the prevention of hospital-associated infections in premature, very low birth weight (VLBW) infants. We have completed the enrollment phase of a 2,000 patent pivotal Phase III trial of Veronate®, and we anticipate data from this trial to be available in the second quarter of 2006. Veronate® has been granted both Fast Track and Orphan Drug status by the FDA and has been designated an orphan medicinal product by the EMEA in Europe. Our second product candidate, Aurexis®, is being evaluated in clinical trials as a first-line therapy, in combination with standard of care antibiotics, to treat serious Staphylococcus aureus (S. aureus) bloodstream infections in hospitalized patients.

Location

9005 Westside Parkway
Alpharetta
Georgia
30004
United States of America

Contact

Phone: 678.746.1100


Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

Inhibitex, Inc.

Inhibitex, Inc., headquartered in Alpharetta, Georgia, is a biopharmaceutical company focused on developing innovative products to prevent and treat serious infectious diseases. T...

Inhibitex

We are a biopharmaceutical company focused on the discovery, development and commercialization of novel antibody-based products for the prevention and treatment of serious bacterial and fungal infecti...

More Information about "Inhibitex" on BioPortfolio

We have published hundreds of Inhibitex news stories on BioPortfolio along with dozens of Inhibitex Clinical Trials and PubMed Articles about Inhibitex for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Inhibitex Companies in our database. You can also find out about relevant Inhibitex Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record